Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development

Blood

Volumn 114, Issue 9, 2009, Pages 1784-1793

  Le Campion, Armelle ^a   Gagnerault, Marie Claude ^b   Auffray, Cédric ^a   Bécourt, Chantal ^b   Poitrasson Rivière, Maud ^a   Lallemand, Eliette ^a   Bienvenu, Boris ^a   Martin, Bruno ^a   Lepault, Françoise ^a   Lucas, Bruno ^a  

^a Cochin Hospital ^*  (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; CD3 ANTIGEN; CD45 ANTIGEN; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE COURSE; IN VIVO STUDY; LYMPHOCYTOPENIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; METHODOLOGY; NONOBESE DIABETIC MOUSE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD45; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; FLOW CYTOMETRY; LIGANDS; LYMPHOPENIA; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; T-LYMPHOCYTES;

EID: 70349249991     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-12-192120     Document Type: Article

References (48)

1. Von Boehmer H, Teh H, Kisielow P. The thymus selects the useful, neglects the useless and destroys the harmful. Immunol Today. 1989;10:57-61. (Pubitemid 19041704)
2. Robey E, Fowlkes BJ. Selective events in T cell development. Annu Rev Immunol. 1994;12:675-705.
3. + thymocyte differentiation. Immunity. 1996;5:461-477.
4. Tough DT, Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med. 1994; 179:1127-1135.
5. Bruno L, von Boehmer H, Kirberg J. Cell division in the compartment of naive and memory T lymphocytes. Eur J Immunol. 1996;26:3179-3185. (Pubitemid 26411529)
6. Tanchot C, Lemonnier FA, Pérarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science. 1997;276:2057-2062. (Pubitemid 27443614)
7. + T-cell pool in a nonlymphopenic environment. Blood. 2006;108:270-277.
8. Jameson SC. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol. 2002;2:547-556.
9. Martin B, Bourgeois C, Dautigny N, Lucas B. On the role of MHC class II molecules in the survival and lymphopenia-induced proliferation of peripheral CD4+ T cells. Proc Natl Acad Sci U S A. 2003;100:6021-6026. (Pubitemid 36576924)
10. Min B, Foucras G, Meier-Schellersheim M, Paul WE. Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc Natl Acad Sci U S A. 2004;101:3874-3879. (Pubitemid 38381070)
11. Seddon B, Zamoyska R. TCR and IL-7 receptor signals can operate independently or synergize to promote lymphopenia-induced expansion of naive T cells. J Immunol. 2002;169:3752-3759.
12. Min B, Yamane H, Hu-Li J, Paul WE. Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. J Immunol. 2005;174:6039-6044. (Pubitemid 40663791)
13. Kieper WC, Troy A, Burghardt JT, et al. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J Immunol. 2005;174:3158-3163. (Pubitemid 40354015)
14. Marleau AM, Sarvetnick N. T cell homeostasis in tolerance and immunity. J Leukoc Biol. 2005;78: 575-584.
15. Krupica T Jr, Fry TJ, Mackall CL. Autoimmunity during lymphopenia: a two-hit model. Clin Immunol. 2006;120:121-128.
16. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996;184:387-396. (Pubitemid 26324092)
17. Gleeson PA, Toh BH, van Driel IR. Organ-specific autoimmunity induced by lymphopenia. Immunol Rev. 1996;149:97-125.
18. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int Immunol. 1993;5:1461-1471.
19. Nakajima H, Hiyama Y, Takamori H, Tsukada W. Cell-mediated transfer of collagen-induced arthritis in mice and its application to the analysis of the inhibitory effects of interferon-γ and cyclophosphamide. Clin Exp Immunol. 1993;92:328-335. (Pubitemid 23151046)
20. Shen S, Ding Y, Tadokoro CE, et al. Control of homeostatic proliferation by regulatory T cells. J Clin Invest. 2005;115:3517-3526. (Pubitemid 43121839)
21. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell. 2004;117:265-277. (Pubitemid 38496245)
22. Calzascia T, Pellegrini M, Lin A, et al. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc Natl Acad Sci U S A. 2008; 105:2999-3004. (Pubitemid 351723657)
23. Kieper WC, Jameson SC. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci U S A. 1999;96:13306-13311.
24. Cho BK, Rao VP, Ge Q, Eisen HN, Chen J. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med. 2000;192:549-556. (Pubitemid 30666255)
25. Murali-Krishna K, Ahmed R. Naive T cells masquerading as memory T cells. J Immunol. 2000; 165:1733-1737.
26. + T cells convert to anergic or memory-like cells in T cell-deprived recipients. Eur J Immunol. 2001;31:2256-2265.
27. Berzins SP, Venanzi ES, Benoist C, Mathis D. T-cell compartments of prediabetic NOD mice. Diabetes. 2003;52:327-334. (Pubitemid 36173186)
28. D'Alise AM, Auyeung V, Feuerer M, et al. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci U S A. 2008;105:19857-19862.
29. Haskins K, Portas M, Bergman B, Lafferty K, Bradley B. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci U S A. 1989;86:8000-8004. (Pubitemid 19265307)
30. Luhder F, Katz J, Benoist C, Mathis D. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities. J Exp Med. 1998;187:379-387. (Pubitemid 28080067)
31. Kanagawa O, Militech A, Vaupel BA. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice. J Immunol. 2002;168: 6159-6164. (Pubitemid 34620034)
32. Kishimoto H, Sprent J. A defect in central tolerance in NOD mice. Nat Immunol. 2001;2:1025-1031. (Pubitemid 33069497)
33. Zucchelli S, Holler P, Yamagata T, Roy M, Benoist C, Mathis D. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity. 2005;22:385-396. (Pubitemid 40387479)
34. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/ suppressive state. Int Immunol. 1998;10: 1969-1980.
35. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188:287-296.
36. + regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol. 2005;6:1152-1159.
37. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005;201:723-735.
38. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol. 2005;6:1142-1151. (Pubitemid 41541792)
39. + regulatory T cells is indexed to the number of IL-2-producing cells. J Immunol. 2006;177:192-200.
40. + regulatory T cells. Nat Med. 2005; 11:1238-1243.
41. + regulatory T cells. J Immunol. 2007;178:280-290.
42. + regulatory T cell development. J Immunol. 2008;181:3285-3290.
43. Monteleone G, Pallone F, MacDonald TT. Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses. Trends Immunol. 2008;29:290-294.
44. Davis ID, Skak K, Smyth MJ, Kristjansen PE, Miller DM, Sivakumar PV. Interleukin-21 signaling: functions in cancer and autoimmunity. Clin Cancer Res. 2007;13:6926-6932. (Pubitemid 350276871)
45. Clough LE, Wang CJ, Schmidt EM, et al. Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. J Immunol. 2008; 180:5393-5401.
46. Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci U S A. 2008;105:14028-14033.
47. Milner JD, Ward JM, Keane-Myers A, Paul WE. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2- associated inflammatory disease. Proc Natl Acad Sci U S A. 2007;104:576-581. (Pubitemid 46123067)
48. + T cells. J Exp Med. 1987;166:823-832.